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ABSTRACT
ThisreviewtakesasecondlookatasetofmRNAsthat
purportedly employ an alternative mechanism of ini-
tiation when cap-dependent translation is reduced
during mitosis or stress conditions. A closer look is
necessary because evidence cited in support of the
internal initiation hypothesis is often flawed. When
putative internal ribosome entry sequences (IRESs)
are examined more carefully, they often turn out to
harbor cryptic promoters or splice sites. This under-
mines the dicistronic assay, wherein IRES activity
is measured by the ability to support translation
of the 30 cistron. Most putative IRESs still have not
been checked carefully to determine whether the
dicistronic vector produces only the intended dicis-
tronicmRNA.ThewidespreaduseofthepRFvectoris
a major problem because this vector, which has
Renillaluciferaseasthe50cistronandfireflyluciferase
as the 30 cistron, has been found to generate spliced
transcripts. RNA transfection assays could theoreti-
cally circumvent these problems, but most candidate
IRESs score very weakly in that test. The practice of
calling even very weak results ‘positive’ is one of the
problems discussed herein. The extremely low effici-
ency of putative IRESs is inconsistent with their pos-
tulated biological roles.
‘...if it is a Miracle, any sort of evidence will answer, but if it
is a Fact, proof is necessary’
—Mark Twain, Letters from the Earth
INTRODUCTION
Generalizations about when and how the internal initiation
mechanism operates are meaningful only if credible examples
underlie the generalizations. A popular idea is that translation
of certain genes might be maintained via internal initiation
when the overall translational capacity is reduced during
mitosis, apoptosis and other special conditions. A recent com-
pilation of cellular mRNAs said to harbor such regulable inter-
nal ribosome entry sequences (IRESs) (1) provides a
convenient starting point—a deﬁned set of examples—for
evaluating this idea. Table 1 herein reproduces, with some
added details, the list of IRESs compiled by Komar and
Hatzoglou (1).
A few candidate IRESs listed in the original table have been
omitted here for reasons explained in the ﬁrst footnote to
Table 1. The reason for omitting six mRNAs described by
Qin and Sarnow (44) might require explication, as the problem
is not unique to that case. Their dicistronic vector contained a
big chunk of the EMCV IRES to which each candidate cellular
IRES was appended. Although it was a defective versionof the
EMCV IRES (i.e. not active on its own), there was no good
reason forit to bethereand it might have stacked the deck. The
same vector had been used previouslyto identify IRES activity
in pim-1 mRNA (55), and that claim did not hold up. When the
pim-1 sequencewasre-testedwithoutthe EMCV appendage,it
had no detectable IRES activity; cryptic promoter activity was
found instead (56).
Table 1 lists 27 mRNAs. In none of these cases is the
evidence for IRES activity convincing. Most can be dismissed
either because the sequence harbors a transcriptional promoter
or splice site, or because the demonstrated IRES activity is
extremely weak, or for both reasons. The next section brieﬂy
discusses these and other deﬁciencies in the evidence for inter-
nal initiation. Some (not all) of these problems were pointed
out in earlier reviews, but it is important to see how these
issues apply to the set of mRNAs currently held to be trans-
lated via internal initiation.
OVERVIEW OF EVIDENCE AND REASONING
Problems with dicistronic test for IRES activity
The ability to demonstrate internal initiation should not
depend on the choice of reporter genes, but it does. Hennecke
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Nucleic Acids Research, 2005, Vol. 33, No. 20 6595et al. (57) found that the poliovirus IRES works when inserted
into pRF but not when the order of reporter genes is reversed.
The function of the c-myc IRES also depends strongly on the
choice of vectors: the c-myc sequence supported efﬁcient
translation of the 30 cistron when inserted into pRF (10,11);
but when tested with a bgal/CAT vector, the c-myc IRES was
20- to 100-fold less active than the EMCV control (2). The
discovery of a splice-donor sequence within the Renilla
luciferase (Rluc) gene (5) might explain why detection
of ‘IRES’ activity is so easy using the pRF vector. Whatever
the reason, it is worrisome that so many claims of internal
initiation are based on tests with one particular dicistronic
vector (Table 1).
For some entries in the table, the published studies included
noRNA analyses atall.Inmany othercases,theRNA analyses
werenotsufﬁcienttoprove thatthedicistronicvector produces
only the intended dicistronic mRNA. The table shows a
remarkable number of cases in which followup experiments
indeed uncovered splicing or cryptic promoter activity within
a putative IRES.
For some other entries, the possibility of a cryptic promoter
was ruled out but the possibility of splicing was not addressed.
Splicing cannot be ruled out simply by demonstrating that the
dicistronic mRNA supports low-level translation in vitro.A
different artifact—namely, cleavage of the mRNA—might
undermine in vitro tests, especially when the temperature is
raised to 37 C (13,58,59) or the incubation is prolonged [e.g.
90 min in Ref. (9,24,51)]. Investigators sometimes point to
lack of inhibition by cap analogs, or by a base-paired structure
appended to the 50 end of the mRNA, as evidence for internal
initiation; but translation from broken mRNAs also would be
resistant to those manipulations.
When translation of the 30 cistron is inefﬁcient (see next
section), northern blots—proffered as evidence that the
dicistronic mRNA is the sole transcript—mean nothing.
Northern blotting sometimes fails to detect a low-
abundance monocistronic mRNA which can be demonstrated
via more sensitive assays (5,60). Thus, entries in Table 1 are
marked ‘inadequate RNA analysis’ when the only attempted
assay was northern blotting or when an RNase-protection
assay, used to verify presence of the intended dicistronic
mRNA, did not rule out the possibility that a monocistronic
transcript might also be produced.
Picornavirus RNAs are often used as controls when testing
other candidate IRESs, but these controls also need controls
to check for splicing and cryptic promoters. Smaller-
than-dicistronic mRNAs are produced sometimes even with
putative IRESs from picornaviruses (61–63).
Weak IRES or no IRES?
When the 30 cistron is translated very inefﬁciently, there are
two reasons to worry. One concerns the sensitivity required for
meaningful RNA analyses, as explained above. The other is
whether the results of the dicistronic test should even be called
positive.
An underlying problem is that the negative control—e.g. the
‘empty’ pRF vector with no special intercistronic insert—is
never negative. There is always some translation of the
30 cistron, and this unexplained background expression is
not constant. Background translation of the 30 ﬁreﬂy luciferase
(Fluc) cistron varied >10-fold when three different negative
controls were tested by RNA transfection [Figure 5C in
Ref. (9)]. When tested in vitro, translation of the 30 cistron
increased 10-fold upon simply lengthening the intercistronic
domain [Figure 9 in Ref. (64)]. Whatever the reason for this
background, its variability would seem to set a lower limit on
what level of expression constitutes a credible positive result
when a candidate IRES is tested.
Tests for internal initiation often use the putative IRES from
EMCV as a high-end control, but it really is not very high.
When a dicistronic mRNA containing the EMCV sequence
was tested by RNA transfection, the yield of Fluc from the
30 cistron was only 3% of the Rluc yield (56). By convention,
thiscountsasapositivecontrolbecauseitrepresentsan18-fold
increase over Fluc production from the empty pRF vector; but
readers need to understand what ‘18-fold increase over the
empty vector’ really means: even the paradigmatic EMCV
IRES functions poorly. The putative IRES from hepatitis C
virus(HCV)alsoisusedoftenasapositivecontrol,butitshould
not be: it is unsuitable for DNA transfection assays because
the HCV sequence harbors a cryptic promoter (65), and it
barely supports translation when dicistronic mRNAs are
tested directly in vitro or via RNA transfection [see point
(iv) below].
Many entries in Table 1 are marked ‘weak’ without pro-
viding details because the table would be unreadable if every-
thing were written out. Here is what weak means in ﬁve cases
(entries #1, #5, #6, #15 and #18).
(i) When the Apaf-1 sequence was tested by DNA transfec-
tion in HeLa cells using a dicistronic bgal-CAT vector,
Apaf-1 was only  2% as active as the EMCV IRES (2). It
was somewhat more active when tested with the pRF
vector (4).
(ii) The BiP IRES was only  3% as active as EMCV when
testedbyDNAtransfectionusingbgal-CATconstructs(2).
When activity was judged by comparison with an empty
dicistronicCAT-LUCvector,theBiPIRESelevatedtrans-
lationofthe30 cistrononly2.5-fold[Figure5inRef.(28)].
When translational efficiency was assessed in vitro,a
50-fold higher concentration of mRNA had to be used
when the BiP IRES replaced the EMCV IRES (59).
(iii) The putative IRES from cat-1 mRNA was similar in effi-
ciency to BiP when dicistronic constructs were tested by
DNA transfection (23). When translation was tested
in vitro, the yield of LUC from a dicistronic mRNA
(CAT-LUC) containing the cat-1 IRES was only 1% of
the yield from a monocistronic control mRNA [Figure 5C
in Ref. (24)]. Elaborate explanations of how changes in
secondarystructureregulatethefunctionofthecat-1IRES
amounttoputtingthecartbeforethehorse:the4-or5-fold
increase in translation of the 30 cistron when the IRES is
‘activated’ is still so low, given the starting point, that
calling it an IRES is not justified.
(iv) Because splicing was detected when the c-IAP1 sequence
was tested by DNA transfection, those results are not
usable. When tested by RNA transfection, the c-IAP1
sequence increased translation of the 30 cistron only
2-fold, compared with a null control (9). When tested
in vitro, the c-IAP1 sequence supported translation of the
30 Fluc cistron as efficiently as the putative IRES from
6596 Nucleic Acids Research, 2005, Vol. 33, No. 20HCV; but the HCV IRES barely worked. (The autoradio-
gram in Figure 2B in Ref. (9) was not quantified, but it is
clearthattheyieldofFlucfromthedicistronicmRNAwas
much lower than from a monocistronic mRNA.)
(v) When the Bcl-2 sequence was tested by RNA transfection
using a pRF-based vector, Bcl-2 was only 6% as active as
the HCV IRES (8).
Two additional points about efﬁciency need to be mentioned.
One is that a weak IRES such as HCV or BiP is sometimes
made to look stronger by comparing it, not with the empty
vector, but with a construct that has a highly structured inter-
cistronic sequence (8,29,63). The proffered rationale—that the
structured insert ‘reduces readthrough’—makes no sense,
given that eukaryotic ribosomes cannot readthrough (i.e.
cannot reinitiate) following the translation of a full-length
50 cistron. A more reasonable interpretation is that the struc-
tured insert precludes cleavage of the dicistronic mRNA. The
‘IRES’ looks strong only because it replaces this inhibitory
element.
The second point is that, in many cases, the efﬁciency is
concealed by setting at 1.0 (or 100%) the yield of protein
obtained from the 30 cistron in the presence of the candidate
IRES—without reference even to the empty dicistronic
vector—and then focusing on accessory proteins or growth
conditions which slightly increase translation of the 30 cistron
[Figure 5 in Ref. (27); (58,66–69)]. Thoughtful readers will
recognize that this tactic dodges the basic question of whether
the ‘IRES’ functions well enough to be called an IRES.
A closer look at putative IRES elements
said to function during mitosis
Two problems undermine the hypothesis that, when overall
translation declines during mitosis, the mRNAs that remain
polysome-associated might be translated via internal initia-
tion. One problem is that retention on polysomes is not a
reproducible criterion. Pyronnet et al. (12) reported that
ODC and c-myc mRNAs are retained on polysomes in cells
blocked at G2/M, but these mRNAs were not found on poly-
somes in a followup study (44). The bigger problem is that
ODC and c-myc 50-untranslated regions (50-UTRs) do not
score convincingly when IRES activity is tested directly.
The sequence from ODC mRNA stimulated translation of
the 30 LUC cistron <2.5-fold [Figure 4D in Ref. (12)]. The
putative IRES from c-myc mRNA was extremely weak [1–5%
as active as EMCV, depending on cell type; Ref. (2)] except
when the vector was pRF (10); and the experiments with pRF-
based constructs lacked adequate controls to rule out splicing
or a cryptic promoter.
A putative IRES derived from the coding domain of the
PITSLRE kinase gene scored strongly when ﬁrst tested: it
mediated a 40-fold increase in translation of the 30 bgal cistron
under conditions where only a single form of mRNA could be
detected (70). This nearly convincing story did not hold up,
however. In a followup study with a different vector, the
PITSLRE sequence stimulated translation only  6-fold
[nt 745–1125; Figure 1C in Ref. (13)]. The production of two
protein isoforms from the natural gene is not in doubt:
p110
PITSLRE accumulates throughout the cell cycle while
p58
PITSLRE increases 20-fold in G2/M. What is not certain
is whether both isoforms are translated from the same
mRNA. The natural gene does generate alternatively spliced
transcripts(71).Additionalstudies are needed to determinethe
structure of transcripts produced when the PITSLRE sequence
is transposed to a synthetic dicistronic vector. Control experi-
ments eliminated the possibility of a cryptic promoter (13), but
the possibility of splicing was not ruled out.
The p27
Kip1 protein inhibits cyclin-dependent kinase activ-
ity, causing arrest in the G1 phase. Expression of p27
Kip1
appears to be regulated at the level of translation, as evidenced
by a substantial shift of the mRNA to heavier polysomes
during G0and G1(72);but the mechanism ofregulationcannot
be understood without additional information, such as check-
ing for a possible change in structure of the 50-UTR. Cho et al.
(16) postulate that p27
Kip1 mRNA harbors an IRES which is
enhanced by polypyrimidine tract binding protein (PTB), and
that changes in the concentration of PTB contribute to cell-
cycle control ofp27
Kip1.Neither the claim of internal initiation
nor the putative involvement of PTB is supported by credible
evidence. The results obtained by DNA transfection are not
reliable because cryptic promoter activity has been detected in
the p27
Kip150-UTR(17).Thus, theclaim ofIRES activity must
rest on RNA transfection and in vitro translation experiments.
But those results [Figure 4 and Figure 6F in Ref. (16)] were
presented in a way that conceals the efﬁciency of translation of
the 30 cistron: the Fluc/Rluc yield from a construct bearing the
p27
Kip1 sequence was simply set at 1.0. A 2-fold increase in
Fluc/Rluc ratio when PTB was added to the system, or a 2-fold
decrease when PTB was depleted by small interfering RNA
(siRNA), is cited as evidence that PTB augments the function
of the p27
Kip1 IRES. In this way, attention is directed away
from the basic question—whether p27
Kip1 mRNA indeed pos-
sesses IRES activity—to showing that PTB helps. Demon-
strating slight stimulation by a protein called an ‘IRES
trans-activating factor’ (ITAF) is not a substitute for
showing directly that the mRNA sequence functions as
an IRES.
Are there regulable IRES elements?
Claims of tissue-speciﬁc IRES elements are premature
because the most obvious alternative—a tissue-speciﬁc
change in mRNA structure via splicing or alternative promoter
usage—was not examined. Cre ´ancier et al. (73) claim the
c-myc IRES is developmentally controlled in transgenic
mice, i.e. translation of the 30 Fluc cistron was detected in
embryonic tissues but not in adults. The cursory RNA analyses
were limited to adult tissues, however, leaving the essential
point unexamined. Inadequate RNA analyses also undermine
the claim that the FGF-2 IRES functions speciﬁcally in the
brain of adult mice: only the amount of mRNA, not its
(dicistronic?) structure, was examined in various tissues (31).
Four recent examples show how ‘old problems’ continue to
undermine new reports of regulable IRESs.
(i) During hypoxia, the reduction in overall translation is
modest [e.g. 50% reduction in Figure 2A of Ref. (21)].
Since cap-dependent translation is not fully shut off, an
alternativemechanismofinitiationisnotreallyrequiredto
explain the continued translation during hypoxia of
mRNAs such as Tie2 (74) and HIF-1a (21). When the
Tie250-UTRwastestedforIRESactivityviatransposition
toasyntheticdicistronicmRNA,itwasonly3%asactiveas
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no sense to invoke this meager IRES activity (if such
it is) to explain the sustained translation of Tie2 during
hypoxia;thenumbersdonotaddup.TheHIF-1asequence
was not tested via RNA transfection, and its seemingly
strong IRES activity in DNA transfection experiments
might be explained by a cryptic promoter.
(ii) Questions about efficiency also undermine the claim of
IRES activity in methionine synthase (MS) mRNA (75).
TheMSsequencewasaboutasactiveasBiP,butuseofBiP
as the only positive control sets the bar very low. (The
negative control was made to look worse by inserting, at
the midpoint, a 400 nt chunk of Drosophila antennapedia
cDNA. Simply removing this big, structured insert would
increase translation of the 30 LUC cistron, irrespective of
whether the sequence that replaces it really is an IRES.)
Most experiments sidestepped the question of efficiency
by setting at ‘100%’ the LUC yield from a dicistronic
construct that contains the MS sequence. An increase to
‘140%’ in the presence of vitamin B12 is the proffered
evidence for regulation.
(iii) In contact-inhibited differentiated cells, wherein cap-
dependent translation is said to be reduced, translation
of connexin proteins Cx26 and Cx43 is postulated to
occur via internal initiation (76). The basic finding is
that accumulation of Cx26 and Cx43 proteins increases
 10-fold in density-inhibited cancer cells. Because
mRNA levels increased only 2- to 3-fold, the overexpres-
sionofconnexinswassaidtobe‘mainlytranslational.’But
thatconclusionisnotjustifiedontwocounts:anincreasein
translation might be secondary to a change in structure of
the 50-UTR, which was not checked; and increased accu-
mulation of connexin proteins might result from slower
turnover rather than increased synthesis. The latter possi-
bilitywasnotruledoutbyanexperimentwhichmonitored
protein accumulation after labeling cells for 30 min with
[
35S]methionine. The amount of protein that accumulates
over 30 min is the sum of synthesis plus degradation; a
much shorter pulse (e.g. 3 min) is required to measure the
rate of protein synthesis per se (77).
The up-regulation was attributed to IRES-mediated
translation based on two additional findings: elevated
production of Cx26 and Cx43 proteins was insensitive
to rapamycin, which impairs the function of eukaryotic
initiation factor 4E (eIF4E); and the 50-UTRs of Cx26
and Cx43 were able to support translation from a
dicistronic vector. The first finding is meaningful only
if rapamycin treatment of these cells indeed inhibits
cap-dependent translation. Theauthorssay thiswas estab-
lishedbyshowingthatrapamycinstronglyreducesexpres-
sion of cyclin D1 (as it does); but manipulation of eIF4E
is known to control the expression of cyclin D1 at the
levelofmRNAtransport,nottranslation(78).Thus,cyclin
D1 is an inappropriate control, and the point was not
proven. As for the experiments with dicistronic vectors,
suffice it to say that no RNA analyses were carried out.
A control experiment ruled out the possibility of a
cryptic promoter in the Cx26 sequence, but the Cx43
sequence was not tested for promoter activity, and the
possibility of splicing was not examined in either case.
The vector was pRF.
(iv) Miuraetal.(79)postulateaninducibleIREStoexplainthe
increased translation of utrophin when muscle regenera-
tion is induced by treating mice with cardiotoxin. When
IRESactivitywastestedviaasyntheticdicistronicmRNA,
however, cardiotoxin caused only a 3-fold increase in
translation of the 30 CAT cistron [Figure 5B in Ref. (79)].
Thiscontrastswitha14-foldincreaseintranslationofutro-
phin from the natural mRNA [Figure 2A in Ref. (79)].
Even if the magnitude of induction were greater in
tests with the dicistronic mRNA, the point would not be
proven. We have to know whether the absolute yield of
(CAT) protein from the dicistronic construct is anywhere
neartheamountofproteinproducednormallyfrommono-
cistronic utrophin mRNA; i.e. does the ‘IRES’ work well
enough to function in the real world? This is unknowable
because the only point of reference was the empty dicis-
tronic vector.
Thebiggestfaultwiththeutrophinstorymightbefailure
to examine the natural phenomenon carefully before
attempting to reconstruct it. Several studies in mice docu-
mented increased production of utrophin protein under
conditions where the amount of mRNA showed little or
no change; but these studies did not check for a possible
changeinstructureofthemRNA[e.g.shorteningofthe50-
UTR], which could underlie the increase in translation.
Ideas borrowed (wrongly) from picornaviruses
Cellular mRNAs that remain polysome-associated during
poliovirus infection are said to be probable candidates for
internal initiation (55,80,81). Pim-1, eIF4G, BiP and c-myc
were among the mRNAs found to be retained on polysomes;
and experiments with dicistronic DNA vectors were said to
conﬁrm IRES activity in each case. But subsequent experi-
ments uncovered cryptic promoter activity in the pim-1 and
eIF4G sequences (56,60). When tested by RNA transfection,
the pim-1 and c-myc sequences displayed no IRES activity
(10,56), and eIF4G barely scored [e.g. the Fluc yield was  1%
of Rluc in Figure 5 of Ref. (82)]. The BiP 50-UTR scores very
weakly in tests for internal initiation no matter which assay is
used (see above).
The point here is not just that these cellular mRNAs
arguably were misidentiﬁed as IRESs, but that the reasoning
on which the original predictions were based is faulty. The
popular belief that cleavage of eIF4G impairs cap-dependent
translation is not upheld by the facts. In neuronal cells infected
by poliovirus, eIF4G was cleaved extensively by 3.5 h post-
infection and cleavage was complete by 5 h, but host protein
synthesis continued unabated for at least 9 h (83). Reconstruc-
tion experiments conﬁrm that the truncated form of eIF4G
generated by the poliovirus-encoded protease can still support
translation of capped mRNAs (84). Thus, translation under
conditions where eIF4G gets cleaved is not grounds for pos-
tulating the involvement of an IRES.
ITAFs are another idea that originated with picornaviruses.
These proteins are used as a crutch to explain whatever needs
explaining; but it is a phantom crutch. To explain why star-
vation for 9 h is required to activate the putative IRES in cat-1
mRNA, Yaman et al. (69) postulate that an ‘essential ITAF’
has to be synthesized; but no evidence for such a protein has
been uncovered. In other cases, although a protein has been
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ments IRES function are based on weak, convoluted evidence
are based on weak, convoluted evidence. An earlier review
(85) explains what ‘convoluted’ means in two cases (86,87). A
recent study which declares PTB to be a ‘universal ITAF’ (88)
is ﬂawed from the outset: none of the mRNA sequences
shown to bind PTB was shown convincingly to harbor
IRES activity. The proffered northern blots were not adequate
to rule out splicing when the sequences were tested by DNA
transfection using pRF-based vectors. And the claim that the
candidate IRESs support translation in vitro is meaningless
because the efﬁciency of translation of the 30 Fluc cistron was
never revealed: the Fluc/Rluc yield from a dicistronic mRNA
containing the candidate IRES was set at 1.0 and shown to
increase 2- or 3-fold upon addition of PTB [e.g. Figure 4G in
Ref. (88)].
There simply is no meaningful evidence that RNA-binding
proteins augment internal initiation. The p27
Kip1/PTB story
discussed above typiﬁes the ﬁndings: a protein which has
no recognizable connection to translation (PTB is a splicing
factor) produces a very small effect upon a target sequence
which arguably is not an IRES. PTB is one of about a dozen
proteins that bind weakly to the p27
Kip1 mRNA leader
sequence [Figure 1 in Ref. (16)], which raises the question
of why the authors chose to focus on that particular protein.
The reason they give is that PTB binds (strongly) to the EMCV
IRES. What this reasoning-by-analogy ignores is that the
binding of PTB to EMCV mRNA has no real functional
consequences: although PTB stimulated translation using a
laboratory-derived version of the 50-UTR, translation was
independent ofPTBwhenthe wild-type 50-UTR was appended
to the natural coding domain of EMCV (89).
With poliovirus, both PTB and La autoantigen are said to
function as ITAFs. Binding of PTB is barely detectable even
with the wild-type 50-UTR, however, and the suggestion that
inefﬁcient binding of PTB might account for the attenuation of
vaccine strains makes no sense (90). In cells depleted of La,
production of viral proteins was reduced only late in the infec-
tion when a secondary burst of protein synthesis occurs from
newly synthesized mRNAs (91). Thus, the effects of La pro-
tein might be on viral RNA synthesis rather than directly on
viral translation. Only one experiment in that study directly
tested IRES activity: expression from a dicistronic pRF-based
vector was examined in cells co-transfected with siRNA
against La. The effect of depleting La was small (a 3-fold
reduction in Fluc translation) and the experiment was inter-
preted blindly (without RNA analyses).
CLOSING ARGUMENTS
When nature offers a clue, it should not be ignored. The fact
that eukaryotic cells produce no natural dicistronic mRNAs
(other than those explicable by leaky scanning) is strong
grounds for questioning the internal initiation hypothesis.
The dicistronic mRNAs produced by some plant and animal
viruses only underscore the point: these transcripts are struc-
turally dicistronic but functionally monocistronic, i.e. only the
50 proximal cistron gets translated [reviewed in (92,93)]. Even
picornaviruses do not employ dicistronic mRNAs: a single
cistron encodes one large ‘polyprotein’ which is cleaved
post-translationally to generate an array of viral proteins.
Another reason to doubt the internal initiation hypothesis is
that the structural evidence does not cohere. There is no hint
of a common structure among putative IRES elements from
cellular mRNAs. ‘Complex secondary and tertiary structure’
(1) is not a deﬁnition. The cellular 50-UTRs said to be IRESs
bear no resemblance to picornavirus 50-UTRs, and thus the
suggestion that ‘viruses captured their IRESs from cellular
mRNAs’ makes no sense (94).
Advocates of internal initiation protested loudly when deﬁ-
ciencies in the evidence were pointed out (95), but the deﬁ-
ciencies were so obvious that editors began asking for the
missing controls. Unfortunately, this has not clariﬁed the
story because, even when control experiments reveal strong
cryptic promoters or splice sites, advocates persist in calling
the sequence an IRES as long as a very low level of activity
can be demonstrated via RNA transfection or translation
in vitro. ‘Once an IRES, always an IRES’ seems to be the
rule. To get around this, editors will have to do more than ask
whether cryptic promoters were ruled out. The section above
entitled ‘weak IRES or no IRES?’ might merit re-reading.
Attempts to explain why IRES elements exist in cellular
mRNAs are plagued by contradictions. One textbook tells us
that internal initiation ‘allows selected mRNAs to be trans-
lated at a high rate despite a general decrease in the cell’s
capacity to initiate protein synthesis’ [(96), emphasis added].
The reality is that putative IRESs are extremely inefﬁcient.
Confronted by this uncomfortable fact, advocates now argue
that internal initiation has to be inefﬁcient to ensure that
critical proteins are not over-produced (1). But that problem
already has a solution: mRNAs that encode potent growth-
regulatory proteins usually have AUG-burdened or highly
structured 50-UTRs which ensure that translation via scanning
will be appropriately constrained (92,93,97,98). Internal ini-
tiation was supposed to be a way to circumvent this con-
straint, not a way to ensure inefﬁcient translation. Advocates
argue that even low-efﬁciency internal initiation can help by
sustaining production of essential proteins when cap-
dependent translation is impaired, as happens during mitosis.
But readers should understand that ‘impaired’ means only
that translation is reduced to  30% of normal (99). The
normal translation mechanism operating at 30% capacity
is still far more efﬁcient than the IRESs that purportedly
function during mitosis.
These deﬁciencies in the rationale are of secondary impor-
tance. The main problem is that there is still no credible evi-
dence forIRES elements inmRNAs of cellular origin. Inmany
cases (e.g. p27
Kip1, connexins, c-myc, BiP) the gene in ques-
tion really is up-regulated under certain conditions. The insis-
tence on seeing this through the lens of the internal initiation
hypothesis—even when no evidence supports that
interpretation—only delays discovering how the regulation
really is accomplished.
Because co-expression of genes is important in biotechnol-
ogy, IRES elements are often tried, not always with success. A
pervasive problem is that, even with the paradigmatic EMCV
IRES, the yield of protein from the 30 cistron is usually much
lower than from the 50 cistron. A recent study resorted to an
alternative mechanism to achieve equimolar production of
heavy and light antibody chains: the two cistrons were
fused, so that translation of one large cistron produced a
‘polyprotein’ from which the heavy and light chains were
Nucleic Acids Research, 2005, Vol. 33, No. 20 6599subsequently derived by proteolysis (100). This idea, bor-
rowed from picornaviruses, actually works.
The fact that many people profess belief in internal initia-
tion does not make internal initiation a fact. Many people also
believe Abner Doubleday invented baseball. Examination of
the evidence reveals contradictions galore.
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